# Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.

> **NCT07426653** · — · COMPLETED · sponsor: **Florence Nightingale Hospital, Istanbul** · enrollment: 298 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07426653
- **Lead sponsor:** Florence Nightingale Hospital, Istanbul
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07426653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07426653, "Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07426653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*